Cinnamic acid and its derivatives inhibit fructose-mediated protein glycation

International Journal of Molecular Sciences

Volumn 13, Issue 2, 2012, Pages 1778-1789

  Adisakwattana, Sirichai ^a   Sompong, Weerachat ^a   Meeprom, Aramsri ^a   Ngamukote, Sathaporn ^a   Yibchok Anun, Sirintorn ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Advanced glycation end products; Cinnamic acid; Diabetic complications; Fructose; Glycation

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMYLOID; CINNAMIC ACID; CINNAMIC ACID DERIVATIVE; FRUCTOSAMINE; FRUCTOSE; LYSINE DERIVATIVE; N EPSILON (CARBOXYMETHYL)LYSINE; SERUM ALBUMIN; UNCLASSIFIED DRUG; BOVINE SERUM ALBUMIN; LYSINE; N(6)-CARBOXYMETHYLLYSINE;

ARTICLE; BETA SHEET; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; FRUCTOSE METABOLISM; INHIBITION KINETICS; LIPID OXIDATION; OXIDATION; OXIDATIVE STRESS; PROTEIN CARBONYLATION; PROTEIN CONTENT; PROTEIN GLYCOSYLATION; STRUCTURE ANALYSIS; ANALOGS AND DERIVATIVES; ANIMAL; BOVINE; CHEMISTRY; DOWN REGULATION; DRUG EFFECTS; GLYCOSYLATION; IN VITRO STUDY; METABOLISM; OXIDATION REDUCTION REACTION;

BOVINAE;

ANIMALS; CATTLE; CINNAMATES; DOWN-REGULATION; FRUCTOSE; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; IN VITRO TECHNIQUES; LYSINE; OXIDATION-REDUCTION; PROTEIN CARBONYLATION; SERUM ALBUMIN, BOVINE;

EID: 84857671056     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13021778     Document Type: Article

References (32)

1. Booth, A.A.; Khalifah, R.G.; Todd, P.; Hudson, B.G. In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). J. Biol. Chem. 1997, 272, 5430-5437.
2. Cohen, G.; Riahi, Y.; Alpert, E.; Gruzman, A.; Sasson, S. The roles of hyperglycaemia and oxidative stress in the rise and collapse of the natural protective mechanism against vascular endothelial cell dysfunction in diabetes. Arch. Physiol. Biochem. 2007, 113, 259-267.
3. Khazaei, M.R.; Bakhti, M.; Habibi-Rezaei, M. Nicotine reduces the cytotoxic effect of glycated proteins on microglial cells. Neurochem. Res. 2010, 35, 548-558.
4. Schmidt, A.M.; Stern, D. Atherosclerosis and diabetes: The RAGE connection. Curr. Atheroscler. Rep. 2000, 2, 430-436.
5. Brownlee, M. Advanced protein glycosylation in diabetes and aging. Annu. Rev. Med. 1995, 146, 223-234.
6. Wu, C.H.; Huang, S.M.; Lin, J.A.; Yen, G.C. Inhibition of advanced glycation endproduct formation by foodstuffs. Food Funct. 2011, 2, 224-234.
7. Bolton, W.K.; Cattran, D.C.; Williams, M.E.; Adler, S.G.; Appel, G.B.; Cartwright, K.; Foiles, P.G.; Freedman, B.I.; Raskin, P.; Ratner, R.E.; et al. ACTION I Investigator Group. Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy. Am. J. Nephrol. 2004, 24, 32-40.
8. Thornalley, P.J. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Arch. Biochem. Biophys. 2003, 419, 31-40.
9. Jin, S.; Cho, K.H. Water extracts of cinnamon and clove exhibits potent inhibition of protein glycation and anti-atherosclerotic activity in vitro and in vivo hypolipidemic activity in zebrafish. Food Chem. Toxicol. 2011, 49, 1521-1529.
10. Saraswat, M.; Reddy, P.Y.; Muthenna, P.; Reddy, G.B. Prevention of non-enzymic glycation of proteins by dietary agents: Prospects for alleviating diabetic complications. Br. J. Nutr. 2009, 101, 1714-1721.
11. Peng, X.; Ma, J.; Chao, J.; Sun, Z.; Chang, R.C.; Tse, I.; Li, E.T.; Chen, F.; Wang, M. Beneficial effects of cinnamon proanthocyanidins on the formation of specific advanced glycation endproducts and methylglyoxal-induced impairment on glucose consumption. J. Agric. Food Chem. 2010, 58, 6692-6696.
12. Dearlove, R.P.; Greenspan, P.; Hartle, D.K.; Swanson, R.B.; Hargrove, J.L. Inhibition of protein glycation by extracts of culinary herbs and spices. J. Med. Food 2008, 11, 275-281.
13. Lee, E.J.; Kim, S.R.; Kim, J.; Kim, Y.C. Hepatoprotective phenylpropanoids from Scrophularia buergeriana roots against CCl4-induced toxicity: Action mechanism and structure-activity relationship. Planta Med. 2002, 68, 407-411.
14. Natella, F.; Nardini, M.; di, Felice, M.; Scaccini, C. Benzoic and cinnamic acid derivatives as antioxidants: Structure-activity relation. J. Agric. Food Chem. 1999, 47, 1453-1459.
15. Liu, I.M.; Hsu, F.L.; Chen, C.F.; Cheng, J.T. Antihyperglycemic action of isoferulic acid in streptozotocin-induced diabetic rats. Br. J. Pharmacol. 2000, 129, 631-636.
16. Adisakwattana, S.; Chantarasinlapin, P.; Thammarat, H.; Yibchok-Anun, S. A series of cinnamic acid derivatives and their inhibitory activity on intestinal alpha-glucosidase. J. Enzyme Inhib. Med. Chem. 2009, 24, 1194-1200.
17. Adisakwattana, S.; Moonsan, P.; Yibchok-Anun, S. Insulin-releasing properties of a series of cinnamic acid derivatives in vitro and in vivo. J. Agric. Food Chem. 2008, 56, 7838-7844.
18. Shaw, J.N.; Baynes, J.W.; Thorpe, S.R. N epsilon-(carboxymethyl) lysine (CML) as a biomarker of oxidative stress in long-lived tissue proteins. Methods Mol. Biol. 2002, 186, 129-137.
19. Ahmed, N. Advanced glycation endproducts-Role in pathology of diabetic complications. Diabetes Res. Clin. Pract. 2005, 67, 3-21.
20. Qin, B.; Panickar, K.S.; Anderson, R.A. Cinnamon: Potential role in the prevention of insulin resistance, metabolic syndrome, and type 2 diabetes. J. Diabetes Sci. Technol. 2010, 4, 685-693.
21. Morozumi, S. Isolation, purification, and antibiotic activity of o-methoxycinnamaldehyde from cinnamon. Appl. Environ. Microb. 1978, 36, 577-583.
22. Chiti, F.; Dobson, C.M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 2006, 75, 333-366.
23. Uversky, V.N.; Fink, A.L. Conformational constraints for amyloid fibrillation: The importance of being unfolded. Biochim. Biophys.Acta 2004, 1698, 131-153.
24. Wang, S.S.S.; Good, T.A. An overview of Alzheimer's disease. J. Chin. Inst. Chem. Eng. 2005, 36, 533-559.
25. Ardestani, A.; Yazdanparast, R. Inhibitory effects of ethyl acetate extract of Teucrium polium on in vitro protein glycoxidation. Food Chem.Toxicol. 2007, 45, 2402-2411.
26. Bouma, B.; Kroon-Batenburg, L.M.; Wu, Y.P.; Brünjes, B.; Posthuma, G.; Kranenburg, O.; de Groot, P.G.; Voest, E.E.; Gebbink, M.F. Glycation induces formation of amyloid cross-beta structure in albumin. J. Biol. Chem. 2003, 278, 41810-41819.
27. Mossine, V.V.; Linetsky, M.; Glinsky, G.V.; Ortwerth, B.J.; Feather, M.S. Superoxide free radical generation by Amadori compounds: The role of acyclic forms and metal ions. Chem. Res. Toxicol. 1999, 12, 230-236.
28. Sharma, S.D.; Pandey, B.N.; Mishra, K.P.; Sivakami, S. Amadori product and age formation during nonenzymatic glycosylation of bovine serum albumin in vitro. J. Biochem. Mol. Biol. Biophys. 2002, 6, 233-242.
29. Johnson, R.N.; Metcalf, P.A.; Baker, J.R. Fructosamine: A new approach to the estimation of serum glycosylprotein. An index of diabetic control. Clin. Chim. Acta 1983, 127, 87-95.
30. Le Vine, H., III. Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 1999, 309, 274-284.
31. Uchida, K.; Kanematsu, M.; Sakai, K.; Matsuda, T.; Hattori, N.; Mizuno, Y.; Suzuki, D.; Miyata, T.; Noguchi, N.; Niki, E.; et al. Protein-bound acrolein: Potential markers for oxidative stress (covalent modification of protein/antibody/atherosclerosis). Proc. Natl. Acad. Sci. USA 1998, 95, 4882-4887.
32. Ellman, G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959, 82, 70-77.